We identified an increased risk of hepatic dysfunction by biogenic amine ingestion in obesity and confirmed that both blood and liver biomarkers, including CRP, MAO, IL-1β, and PARP-1, are helpful markers for evaluating hepatic function in biogenic amine-induced liver damage in obesity. This evidence concerns the gene CRP and Obesity.